Search

Your search keyword '"McGuire DK"' showing total 534 results

Search Constraints

Start Over You searched for: Author "McGuire DK" Remove constraint Author: "McGuire DK"
534 results on '"McGuire DK"'

Search Results

1. Sodium-Glucose Cotransporter-2 Inhibitors and Major Adverse Cardiovascular Outcomes: A SMART-C Collaborative Meta-Analysis

2. Impact of diabetes on the effects of sodium glucose co-transporter-2 inhibitors on kidney outcomes: collaborative meta-analysis of large placebo-controlled trials

3. Sodium-Glucose Cotransporter 2 Inhibitors and Risk of Hyperkalemia in People with Type 2 Diabetes: A Meta-Analysis of Individual Participant Data from Randomized, Controlled Trials

5. Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy

6. Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease

7. Ertugliflozin and slope of chronic egfr prespecified analyses from the randomized vertis cv trial

8. Risk factors for kidney disorders in patients with type 2 diabetes at high cardiovascular risk: An exploratory analysis (DEVOTE 12)

9. Diabetes-Related Factors and the Effects of Ticagrelor Plus Aspirin in the THEMIS and THEMIS-PCI Trials

10. Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes

12. Cardiovascular Outcomes with Ertugliflozin in Type 2 Diabetes

13. Glomerular Filtration Rate and Associated Risks of Cardiovascular Events, Mortality, and Severe Hypoglycemia in Patients with Type 2 Diabetes: Secondary Analysis (DEVOTE 11)

15. Lower rates of cardiovascular events and mortality associated with liraglutide use in patients treated with basal insulin: A DEVOTE subanalysis (DEVOTE 10)

16. Corrections needed to 2016 ESC and AHA guidelines on heart failure

17. Assessing the safety of sitagliptin in older participants in the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS)

18. Ausgangscharakteristika der DECLARE-TIMI-58-Studienpopulation

20. Efficacy of sotagliflozin 400 mg/day in 1402 patients with type 1 diabetes treated with any insulin regimen (inTandem 3)

21. Corrigendum to: Incidence and outcomes of emergent cardiac surgery during transfemoral transcatheter aortic valve implantation (TAVI): insights from the European Registry on Emergent Cardiac Surgery during TAVI (EuRECS-TAVI)

22. Ezetimibe added to statin therapy after acute coronary syndromes

23. Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus

26. Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus

38. Association between circulating soluble receptor for advanced glycation end products and atherosclerosis: observations from the Dallas Heart Study.

40. Preventing macrovascular complications in type 2 diabetes mellitus: glucose control and beyond.

46. Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease

47. Comparison of coronary artery calcium detected by electron beam tomography in patients with to those without symptomatic coronary heart disease.

49. Treatment strategies to reduce cardiovascular risk in persons with chronic kidney disease and Type 2 diabetes.

50. Baseline kidney function and the effects of dapagliflozin on health status in heart failure in DEFINE-HF and PRESERVED-HF.

Catalog

Books, media, physical & digital resources